ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +5.0% · neue Nettopositionen 0.0% · Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 43.99K | $609,074 | n/a | −2 |
| Q2 2026 | 71 | +3 | 20.21M | $262.94M | +7 | −5 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | n/a | n/a |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | n/a | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | n/a |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | n/a | n/a |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | n/a | n/a |
| Q2 2024 | 10 | n/a | 5.27M | $31.86M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 3.47M | -1.6% | $38.81M | 0.0% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | Point72 Asset Management ✦ | 2.56M | +31.3% | $28.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 2.36M | -5.0% | $26.41M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 4 | Millennium Management ✦ | 1.79M | +28.1% | $20.03M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 976.65K | -0.1% | $10.91M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passiv) | 956.89K | +0.4% | $10.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 933.38K | -12.2% | $10.43M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 556.59K | -4.6% | $6.22M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Marshall Wace ✦ | 338.15K | -16.7% | $3.78M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 270.12K | n/a | $3.02M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Morgan Stanley ✦ | 238.78K | n/a | $2.67M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 12 | Adage Capital Partners ✦ | 150.00K | +50.0% | $1.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 140.73K | +200.0% | $1.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 98.09K | +14.3% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 69.89K | +1.0% | $780,704 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 16 | T. Rowe Price ✦ | 42.03K | +3.3% | $470,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 33.83K | n/a | $377,836 | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 18 | D. E. Shaw & Co. ✦ | 19.54K | -70.1% | $218,273 | 0.0% | ▼ Trim | 6 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 145 Inhaber, 38.52M Anteile, $430.26M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.